Sept 3 (Reuters) -
Pfizer ( PFE ) and Moderna ( MRNA ) on Wednesday defended
their COVID-19 vaccines as having saved millions of lives
worldwide, in separate responses to U.S. President Donald
Trump's demand that pharmaceutical companies should justify the
success of their pandemic drugs.
In a post on Truth Social, Trump asserted that he has seen
"extraordinary" data from companies such as Pfizer ( PFE ), but
criticized them for withholding results from the public and the
Centers for Disease Control and Prevention.
Pfizer ( PFE ) welcomed Trump's demand for openness and pointed to a
dedicated section on its website where clinical trial findings
and safety updates are posted. Moderna ( MRNA ) said it would compile
previously disclosed research and findings on its website.
"We are immensely proud of the role we played in the
historic achievements of Operation Warp Speed," Moderna ( MRNA ) said,
praising the U.S. government's 2020 initiative to accelerate
vaccine development, manufacturing and distribution.
Pfizer ( PFE ) CEO Albert Bourla called Operation Warp Speed a
"profound public health achievement" under Trump's leadership,
adding that the program helped in averting over $1 trillion in
healthcare costs.
The companies' announcements come amid escalating turmoil at
the CDC. Last week, director Susan Monarez was fired less than a
month into her tenure after resisting changes to vaccine policy
that were advanced by Health Secretary Robert F. Kennedy Jr, who
was handpicked by Trump earlier this year.
Her removal sparked the resignation of four senior CDC
officials, who blamed the erosion of public health credibility.
Kennedy has also rescinded federal COVID vaccine
recommendations for pregnant women and healthy children and
halted about $500 million in funding across 22 mRNA vaccine
research projects, including those targeting COVID.
As tensions over federal immunization policies and public
health directives grow, Florida on Wednesday announced plans to
end all state vaccine mandates, including for children to attend
schools.
Kennedy is set to testify before the Senate Finance
Committee later this week, where lawmakers are expected to probe
the CDC's leadership crisis and ongoing policy shifts.
Pfizer ( PFE ) also said new information on its latest vaccine
strain, recently cleared by the U.S. Food and Drug
Administration, will be published in the coming days.